drugset / Trial / NCT03382314
HDDO-1614 Bio Equivalence Study
RandomizedCrossoverOpen-labelOther
Summary
A randomized, open-label, single-dose, crossover study
Timeline
- Start
- 2017-10-16
- Primary completion
- 2017-12-21
- Completion
- 2018-01-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bazedoxifene | Other / unclassified | — | — |
| Comparator | Cholecalciferol | Other / unclassified | — | — |